Skip to main content

Market Overview

UPDATE: Piper Jaffray Upgrades PetMed Express to Buy


Piper Jaffray raises its rating on PetMed Express (NASDAQ: PETS) to Neutral from Underweight and increases its price target to $12 from $10 due to more balanced risk/reward.

Piper Jaffray says, "While the environment remains somewhat challenging and the market remains highly competitive, we believe downside is limited due to: 1) $2 in cash/share and a dividend yield of ~5%, 2) PETS refined marketing message could drive better customer retention, while driving new customer traction, 3) more prudent and effective advertising spend, 4) an earlier and possibly worse tick season due to the dry winter could drive higher than expected flea & tick sales, and 5) encouraging results from our proprietary March 2012 vet survey, which indicates trends continue to improve."

PETS closed at $12.38 a share on Friday.


Related Articles (PETS)

View Comments and Join the Discussion!

Posted-In: Piper JaffrayAnalyst Color Upgrades Price Target Pre-Market Outlook Analyst Ratings

Latest Ratings

FIBKStephens & Co.Downgrades
LEAFCanaccord GenuityDowngrades8.5
AGMSidoti & Co.Downgrades115.0
KEXGabelli & Co.Downgrades
OCGNCantor FitzgeraldDowngrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at